Dry Eye Syndrome
📧 Sign up to get email alerts when something new happens for Dry Eye Syndrome.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2020-08-19EMA Application withdrawn: Xiidra (Lifitegrast) — Novartis Europharm Limited
EMA indicates withdrawal of the application for Xiidra (lifitegrast) by Novartis Europharm Limited for dry eye syndromes.
-
CLINICAL_TRIALS withdrawal · 2018-06-28Clinical Trial Update: Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome [NA]
A clinical trial evaluating pulsed light therapy for meibomian gland dysfunction and dry eye syndrome was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: Tears Substitutions and Their Effects on Higher Order Aberrometery [NA]
A clinical trial investigating tears substitutions and their effects on higher order aberrations in Dry Eye Syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-08Clinical Trial Update: Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye Patients [NA]
The document indicates a pilot study evaluating device prototypes for Dry Eye Syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-15Clinical Trial Update: Treatment of Dry Eye With Supplements [NA]
A clinical trial evaluating supplements for treating dry eye syndromes has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.